Clinical Trial Update: Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHN [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluates induction chemotherapy with docetaxel and cisplatin (Loplatin) followed by concurrent chemoradiotherapy for locally advanced head and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Loplatin (cisplatin)

Snippet

Sponsor: Guiyang Medical University | Conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN